North American Brain Monitoring Devices
The North American Brain Monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders which was valued at $1119.6 million in 2012 and is poised to grow at a CAGR of 9.0% to reach $1834.0 million by 2018. North American Brain Monitoring Devices market segmented by product such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories. The major players extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories

Upcoming

European Brain Monitoring Devices
The European Brain monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders. The European Brain monitoring market was valued at $279.9 million in 2012 and is poised to grow at a CAGR of 8.6% to reach $458.5 million by 2018. The European Brain monitoring Devices market segmented by product such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories. The main companies operating in Brain monitoring devices market and extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, and Advanced Brain monitoring, Inc., Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories

North American Electroencephalograph (EEG)
With the increasing incidence of brain disorders in the U.S. and Canada, the demand for EEG and other brain monitoring devices is expected to rise significantly in the coming years. The North American EEG market is anticipated to grow at a CAGR of 9.60%, from 2013 to 2018. The market report provides an overview of the market dynamics, which includes drivers & restraints, opportunities for new entrants, competitive scenario, and market segmentation. The U.S., Canada, and Mexico are countries considered for this extensive market analysis.

Upcoming

European Electroencephalograph (EEG)
The prevalence of mental and neurological disorders, along with increase in healthcare expenditure is expected to drive the growth of the electroencephalograph market in Europe. The European segment is projected to grow at a CAGR of 9.80%, from 2013 to 2018. The market report offers an overview of market segmentation, drivers & inhibitors, and strategic profiling of top players in the market. Germany, France, and the U.K. are countries that have been considered for the extensive market analysis.

Upcoming

Asian Electroencephalograph (EEG)
The rising incidence of brain disorders such as epilepsy or narcolepsy in the highly populated Asian countries, such as India and China is expected to drive the growth of the electroencephalograph market. The Asian market is projected to grow at a CAGR of 10.40%, from 2013 to 2018. The market report presents a detailed analysis of market share, value chain, and market metrics, which includes drivers, restraints, and upcoming opportunities. Deep dive analysis of key market players are also considered in this report.

Upcoming

Asian Neurointerventional Radiology Devices
The Asian neurointerventional radiology devices market, mainly driven by gradual technological evolution, growing aging and obese population, rising patient pool of ischemic and hemorrhagic stroke, and increasing demand for minimally invasive surgical procedures This market is expected to grow at a growth rate of $125.5 million in 2012 and is expected to grow at a CAGR of 14.8% to reach $268.6 million by 2018. The market is divided into five segments such as neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire). Major players extensively covered in this report are Covidien, PLC (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.).

Upcoming

North American Transcranial Dopplers (TCD)
The North American transcranial doppler market accounted for a market share of 12.62% share in 2013, and is considered as the second largest market in this segment. The rising incidence of brain/mental disorders, especially among the adolescent and aged population, has driven the demand for TCD and other brain monitoring devices in this region. The report offers noteworthy insights on the market share, value chain analysis, market segmentation, and competitive landscape of key industries in this market. It also presents an elaborated overview of company profiles, financials, and recent developments.

Upcoming

European Transcranial Dopplers (TCD)
The aging population in the region, along with the high incidence of brain disorders, is the most important reason for the growth of the European transcranial doppler market. The European market is projected to grow at a CAGR of 5.1%, from 2013 to 2018. The market report provides details of the market valuations, segmentation, competitive scenario, and drivers & restraints among others. Deep dive analysis of key market players are also considered in this report.

Upcoming

Asian Transcranial Dopplers (TCD)
The growing investments made in the research & development segment of the mental healthcare sector, along with growing incidences of mental disorders among the adolescent and elderly populations of this region, are the main factors driving the growth of the Asian transcranial doppler market. The market report provides insights into the market value forecasts, segmentation, market competition, drivers & restraints, and the strategic profiles of the key market players. Japan, China, and India are the major economies considered for market analysis.

Upcoming

North American Neurointerventional Radiology Devices
The North American Neurointerventional radiology Devices Market, mainly driven by gradual technological evolution, growing ageing and obese population, rising patient pool for ischemic and hemorrhagic stroke and increasing demand for minimally invasive surgical procedures. The North american neurointerventional radiology devices market is estimated to be $678.3 million in 2013 and is expected to grow at a CAGR of 5.5% to reach $886.2 million by 2018. The market devided by 5 segments such as neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire). Major players extensively covered in this report are Covidien, PLC (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.).

Upcoming

European Neurointerventional Radiology Devices
The European Neurointerventional radiology Devices Market, mainly driven by gradual technological evolution, growing ageing and obese population, rising patient pool for ischemic and hemorrhagic stroke and increasing demand for minimally invasive surgical procedures The European neurointerventional devices market is estimated to be $427.45 million in 2013 and is expected to grow at a CAGR of 5.0% to reach $546.10 million by 2018. The market devided by 5 segments such as neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire). Major players extensively covered in this report are Covidien, PLC (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.)..

Upcoming

North American External Neurostimulation / Neuromodulation devices Market
The North American external neurostimulation/neuromodulation market is expected to grow significantly due to the growing awareness of consumers and the demand of the aging population to treat prevalent lifestyle & chronic disorders such as arthritis, migraines, and so on. The market report provides information and analysis of the market values, drivers & restraints, competitive scenario, and market opportunities, among others. The U.S., Canada, and Mexico are the major countries that have been considered for this extensive market analysis.

Upcoming

European External Neurostimulation / Neuromodulation devices Market
The European external neurostimulation/neuromodulation market is expected to grow due to the growing demands of the aging population in the region to treat disorders such as arthritis, migraines, and so on. The market report provides market insights such as market values, drivers & restraints, competitive landscape, and market opportunities, among others. The U.K., Germany, France, and Italy, among others, are the major countries that have been considered for this extensive market analysis.

Upcoming

Asian External Neurostimulation / Neuromodulation Market
The Asian external neurostimulation/neuromodulation market is expected to grow due to the growing demands of the population in the region to treat lifestyle & chronic disorders such as arthritis, migraines, and so on. Asia is among the fastest-growing markets for these devices. The market report provides insights into market variables such as market values, drivers & restraints, competitive landscape, and market opportunities. Japan, China, and India, among others, are the major countries that have been considered for this extensive market analysis.